Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Current Leases (2022 - 2025)

Historic Current Leases for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $696000.0.

  • Orchestra BioMed Holdings' Current Leases rose 7620.25% to $696000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $696000.0, marking a year-over-year increase of 7620.25%. This contributed to the annual value of $550000.0 for FY2024, which is 1525.42% down from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Current Leases stood at $696000.0 for Q3 2025, which was up 7620.25% from $642000.0 recorded in Q2 2025.
  • Orchestra BioMed Holdings' 5-year Current Leases high stood at $747000.0 for Q3 2023, and its period low was $350000.0 during Q2 2024.
  • Over the past 4 years, Orchestra BioMed Holdings' median Current Leases value was $645500.0 (recorded in 2023), while the average stood at $601750.0.
  • In the last 5 years, Orchestra BioMed Holdings' Current Leases plummeted by 5198.9% in 2024 and then surged by 8342.86% in 2025.
  • Quarter analysis of 4 years shows Orchestra BioMed Holdings' Current Leases stood at $697000.0 in 2022, then fell by 6.89% to $649000.0 in 2023, then fell by 15.25% to $550000.0 in 2024, then increased by 26.55% to $696000.0 in 2025.
  • Its last three reported values are $696000.0 in Q3 2025, $642000.0 for Q2 2025, and $590000.0 during Q1 2025.